Albozen Gentamicin Sulfate Injection
Gentamicin Sulfate 80mg
Injections · Prescription medication
Albozen Korea Co., Ltd.
MFDS item code 197500220 · Notified 1975.03.25
(Infections) Treatment of sepsis and central nervous system infections, (Skin and soft tissue) Improvement of infections, (Bone and soft tissue) Infection prevention
This injection is effective against various bacteria such as Pseudomonas aeruginosa, Escherichia coli, and Staphylococcus aureus (including penicillin and methicillin-resistant strains) and is used to treat various infectious conditions including sepsis, central nervous system infections, urinary tract infections, respiratory infections, gastrointestinal infections, and skin as well as bone and soft tissue infections. It is particularly utilized in cases where the initial infection is unclear or in situations involving fatal infections caused by Pseudomonas aeruginosa. The eye drops are effective for eye-related infections such as conjunctivitis, keratitis, blepharitis, and dacryocystitis. The ointment is used for treating primary skin infections such as impetigo contagiosa, folliculitis, furuncles, as well as secondary skin infections and wound infections. The implant is used as an adjunctive therapy for postoperative hematogenous purulent osteomyelitis and for the prevention of local infections during bone and soft tissue surgeries. Thus, these medications are broadly utilized in treating various infectious diseases to aid patient recovery.
For adults, administer 3mg (potency) per kg body weight as a divided intravenous or intramuscular injection every 8 hours, and in critically ill cases, administer 5mg (potency) per kg body weight divided into 3–4 injections per day. The usual treatment duration is 7–10 days, and may be extended for severe or resistant cases. Dosages in severe infections and life-threatening situations vary according to body weight. For urinary tract infections, a single dose of 160mg (potency) may be administered once daily.
For children, administer 6–7.5mg (potency) per kg body weight as a divided intravenous or intramuscular injection every 8 hours. For infants, administer 7.5mg (potency) per kg body weight as a divided intravenous or intramuscular injection every 8 hours.
This medication may have glass particles when opening the injection container, so caution is required during use. Extra care should be taken with children and the elderly. This medication should not be used if there is an allergy to this drug or similar antibiotics, or if the patient is pregnant or breastfeeding. Patients with a history of hearing loss, kidney or liver problems, neonates and premature infants, patients with poor nutritional status, or those with muscle diseases should use it carefully. This medication can cause various side effects including shock, allergic reactions, neurological issues, gastrointestinal problems, respiratory issues, blood disorders, and liver and kidney dysfunction, so symptoms should be carefully monitored. In particular, there is a risk of hearing damage and deterioration in kidney function, so treatment duration should be restricted to within 10 days, and if necessary, hearing tests and kidney function tests should be conducted. Caution is also needed when used with specific drugs due to an increased risk of kidney damage or respiratory depression. Women who are pregnant or breastfeeding should not use this medication and should discontinue use while breastfeeding. In children and the elderly, there is a higher risk of reduced kidney function and side effects, so dosage and interval should be adjusted carefully. Overdose may cause kidney impairment, hearing loss, respiratory paralysis, and in such cases, blood dialysis or mechanical respiratory assistance may be necessary. The injection site should be massaged to prevent hardening, and it is best not to administer it with other specific antibiotics. Adequate hydration is required, and it should only be used for the necessary duration to prevent the development of resistant strains.
Cyanosis, respiratory distress, chest discomfort, hypotension, shock, severe allergic reactions, anaphylaxis, eighth cranial nerve disorders (such as hearing loss, hearing impairment, ataxia, etc.), headache, convulsions, disturbance of consciousness, visual disturbances, paralysis, acute renal failure, severe kidney impairment, oliguria, respiratory distress, laryngeal edema, pulmonary fibrosis, liver impairment (risk of jaundice), tendency to bleed, severe edema, hypertension, respiratory depression, respiratory paralysis
Not everyone experiences these, and they can vary from person to person.
This medication should be stored at room temperature, avoiding extremely hot or cold areas. This helps maintain the effectiveness of the medication and ensures safe use.
Colorless transparent injection
50 ampoules (2mL/ampoule x 50)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Gentamicin Sulfate 80mg
Injections · Prescription medication
Albozen Korea Co., Ltd.
Gentamicin Sulfate
Prescription medication
International Pharmaceutical Co., Ltd.
Gentamicin Sulfate 1mg
Cream · OTC medication
Shinpoong Pharmaceutical Co., Ltd.
Gentamicin Sulfate 80mg
Injections · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.
Gentamicin Sulfate
Prescription medication
Kyungdong Pharmaceutical Co., Ltd.
Gentamicin Sulfate
Prescription medication
Kyung Dong Pharmaceutical Co., Ltd.
Gentamicin Sulfate 1mg
Cream · OTC medication
Anguk Pharmaceutical Co., Ltd.
Gentamicin Sulfate 40mg
Prescription medication
Humedics Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.